Trevi Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TRVI Nasdaq 8731 http://www.trevitherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Trevi Therapeutics Inc

Trevi Therapeutics, Inc.'s (NASDAQ:TRVI) top owners are private equity firms with 35% stake, while 32% is held by hedge funds - Jun 4th, 2023 2:45 pm
Trevi Therapeutics to Participate in Upcoming June Conferences - May 30th, 2023 11:30 am
Trevi Therapeutics Announces Publication of Positive Data from the CANAL Trial in IPF Chronic Cough in NEJM Evidence - May 22nd, 2023 8:05 pm
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2023 Earnings Call Transcript - May 16th, 2023 3:46 pm
Q1 2023 Trevi Therapeutics Inc Earnings Call - May 12th, 2023 10:38 am
Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update - May 11th, 2023 8:05 pm
Is a Surprise Coming for Trevi Therapeutics (TRVI) This Earnings Season? - May 10th, 2023 12:48 pm
Trevi Therapeutics to Present at Upcoming Yale Innovation Summit 2023 - May 9th, 2023 11:30 am
Trevi Therapeutics to Report Q1 2023 Financial Results and Provide a Corporate Update on May 11, 2023 - May 4th, 2023 8:05 pm
Trevi Therapeutics Announces Two Presentations on the Phase 2 CANAL Data at the ATS 2023 International Conference - May 2nd, 2023 11:30 am
Trevi Therapeutics to Participate in Upcoming May Investor Events - Apr 27th, 2023 11:30 am
Trevi Therapeutics to Participate in the 22nd Annual Needham Virtual Healthcare Conference - Apr 11th, 2023 8:05 pm
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2022 Earnings Call Transcript - Mar 18th, 2023 6:03 am
Q4 2022 Trevi Therapeutics Inc Earnings Call - Mar 17th, 2023 10:19 am
Trevi Therapeutics Announces Fourth Quarter and Year End 2022 Financial Results and Provides Business Update - Mar 16th, 2023 8:05 pm
Trevi Therapeutics to Report Q4 and Year End 2022 Financial Results and Provide a Corporate Update on March 16, 2023 - Mar 9th, 2023 9:05 pm
Trevi Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering Use of Haduvio™ (nalbuphine ER) for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis - Mar 8th, 2023 12:30 pm
Trevi Therapeutics to Participate in Upcoming March Conferences - Mar 6th, 2023 9:05 pm
Presenting on the Emerging Growth Conference on February 22 Register Now - Feb 21st, 2023 12:00 pm
Trevi Therapeutics to Present at the Emerging Growth Conference on February 22, 2023 - Feb 16th, 2023 12:30 pm